Abstract
Understanding the mechanisms of carcinogenesis is essential to combat cancer. The search for alternative targets for anticancer therapy has gained interest, particularly when focused on upstream pathways. This strategy is particularly relevant when the encoded target proteins are known – or believed - to be “undruggable”, as has been reported for the B-MYB oncogene. This gene, which regulates survival and cell cycle regulation, is overexpressed in cancer and correlates with an unfavorable prognosis. In this study, we focused on the identification of the i-motif (iM) structures in the promoter region of B-MYB as a possible anticancer target, with a complete biophysical characterization and in cell formation assessment using iM-CUT&Tag. Additionally, the interaction of the iM structures with a library of small molecules was investigated.
| Original language | English |
|---|---|
| Article number | 139582 |
| Journal | International Journal of Biological Macromolecules |
| Volume | 296 |
| DOIs | |
| Publication status | Published - 1 Mar 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- B-MYB
- Cancer
- I-DNA
- I-motif
- Ligands
Fingerprint
Dive into the research topics of 'I-motif formation in the promoter region of the B-MYB proto-oncogene'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver